arq 761
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01502800)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- arq 761
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02514031 | Phase 1 | Oct 1, 2015 | The University of Texas, Dallas |
| NCT01502800 | Phase 1 | Dec 1, 2011 | ArQule, The University of Texas, Dallas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The University of Texas, Dallas | Academic/Hospital | 2 | 2 | 1 | 2011 |
| ArQule | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1